Safety and Efficacy of Next Science Gel on Toenail Fungus
ConditionOnychomycosis of Toenail
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNext Science TM
About this trial
This is a 52 week, 20-patient open-label pilot study on the safety and efficacy of Next Science Wound gel in the treatment of mild to moderate Distal Subungual Onychomycosis.
Eligibility criteria
Qualifiers
Ages 18 years old and above
Established and active diagnosis of distal subungual onychomycosis of at least one hallux nail affecting 20-75% of the hallux nail
Positive culture for dermatophytes and positive potassium hydroxide examination
Provide signed and dated informed consent
Disqualifiers
Known allergic reaction to the study products
Unable to provide signed and dated informed consent form
Unable or unwilling to comply with all study procedures and/or unavailable for duration of the study
Thickness of mycotic nail is greater than 3mm
Trial design
Treatments tested in this trial
- Next Science Treatment Gel
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Next Science TM
Lead sponsor
Doctors Research Network
Collaborator
Tissue Analytics
Collaborator
NTS Ventures
Collaborator
Source ClinicalTrials.gov